Immunome Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
/ 
Frequently asked questions
To buy Immunome Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Immunome Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Immunome Inc. is IMNM:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Immunome Inc. has its primary listing on NASDAQ (Small cap). You can trade Immunome Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Immunome Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Immunome Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Immunome Inc..